A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression As a Downstream Effector of Cadherin 1

Overview

Journal J Oncol

Specialty Oncology

Date 2022 Nov 1

PMID 36317124

Authors

Qiang Yan

Youliang Wu

Deguan Li

Yongxiang Li

Affiliations

Soon will be listed here.

Abstract

Background: Genetic studies identified a dozen of frequently mutated genes in gastric cancer, such as cadherin 1 (CDH1) and A-kinase anchoring protein 9 (AKAP9). Of note, genetic alterations including depletion and amplification frameshift mutations of AKAP9 have been observed in 10-15% of gastric cancer patients. However, it is unknown of the expression and role of AKAP9 in gastric cancer. This study is aimed to characterize the expression and function of AKAP9 in gastric cancer.

Methods: Using qRT-PCR, we analyzed the mRNA levels of AKAP9 in gastric cancer patient samples. We investigated the role of AKAP9 in gastric cancer by performing cell proliferation assay, transwell assay, and mouse xenograft assay.

Results: AKAP9 was upregulated in gastric cancer patients. Overexpression of AKAP9 promoted cell proliferation, migration, and gastric tumor growth. Loss of CDH1 elevated AKAP9 mRNA and protein levels.

Conclusion: Our study demonstrates that AKAP9 functions as an oncoprotein to promote gastric cancer cell proliferation, migration, and tumor growth. Moreover, we reveal a possible molecular link showing that AKAP9 is a critical effector downstream of CDH1 in gastric cancer.

Citing Articles

Expression of , , and Genes in Thyroid Lesions: Implications for Differential Diagnosis and Prognosis of Thyroid Carcinomas.

Soboska K, Kusinski M, Pawelczyk K, Migdalska-Sek M, Brzezianska-Lasota E, Czarnecka-Chrebelska K Int J Mol Sci. 2024; 25(1).

PMID: 38203733 PMC: 10778957. DOI: 10.3390/ijms25010562.

Identifying natural products for gastric cancer treatment through pharmacophore creation, 3D QSAR, virtual screening, and molecular dynamics studies.

Jalali Z, Ebrahimi S, Rezadoost H Daru. 2023; 31(2):243-258.

PMID: 37733194 PMC: 10624797. DOI: 10.1007/s40199-023-00480-0.

References

Machado J, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C . E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001; 20(12):1525-8. DOI: 10.1038/sj.onc.1204234. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Gelman I . Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12. Cancer Metastasis Rev. 2012; 31(3-4):493-500. PMC: 3908683. DOI: 10.1007/s10555-012-9360-1. View

Hu Z, Liu Y, Xie L, Wang X, Yang F, Chen S . AKAP-9 promotes colorectal cancer development by regulating Cdc42 interacting protein 4. Biochim Biophys Acta. 2016; 1862(6):1172-81. PMC: 4846471. DOI: 10.1016/j.bbadis.2016.03.012. View

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R . Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013; 31(7):868-75. DOI: 10.1200/JCO.2012.44.4612. View

Diviani D, Soderling J, Scott J . AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation. J Biol Chem. 2001; 276(47):44247-57. DOI: 10.1074/jbc.M106629200. View

Carneiro F, Huntsman D, Smyrk T, Owen D, Seruca R, Pharoah P . Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004; 203(2):681-7. DOI: 10.1002/path.1564. View

Fitzgerald R, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V . Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010; 47(7):436-44. PMC: 2991043. DOI: 10.1136/jmg.2009.074237. View

10.

Langeberg L, Scott J . A-kinase-anchoring proteins. J Cell Sci. 2005; 118(Pt 15):3217-20. DOI: 10.1242/jcs.02416. View

11.

Barber M, Murrell A, Ito Y, Maia A, Hyland S, Oliveira C . Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008; 216(3):295-306. DOI: 10.1002/path.2426. View

12.

Terrin A, Monterisi S, Stangherlin A, Zoccarato A, Koschinski A, Surdo N . PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome. J Cell Biol. 2012; 198(4):607-21. PMC: 3514031. DOI: 10.1083/jcb.201201059. View

13.

Liu X, Chu K . E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014; 2014:637308. PMC: 4145387. DOI: 10.1155/2014/637308. View

14.

Cai H, Jing C, Chang X, Ding D, Han T, Yang J . Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. J Transl Med. 2019; 17(1):189. PMC: 6549266. DOI: 10.1186/s12967-019-1941-0. View

15.

Bang Y, Van Cutsem E, Feyereislova A, Chung H, Shen L, Sawaki A . Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010; 376(9742):687-97. DOI: 10.1016/S0140-6736(10)61121-X. View

16.

Klezovitch O, Vasioukhin V . Cadherin signaling: keeping cells in touch. F1000Res. 2015; 4(F1000 Faculty Rev):550. PMC: 4544379. DOI: 10.12688/f1000research.6445.1. View

17.

Bracke M, van Roy F, Mareel M . The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol. 1996; 213 ( Pt 1):123-61. DOI: 10.1007/978-3-642-61107-0_9. View

18.

Diviani D, Reggi E, Arambasic M, Caso S, Maric D . Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiology. Biochim Biophys Acta. 2015; 1863(7 Pt B):1926-36. DOI: 10.1016/j.bbamcr.2015.11.024. View

19.

Szasz A, Lanczky A, Nagy A, Forster S, Hark K, Green J . Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 2016; 7(31):49322-49333. PMC: 5226511. DOI: 10.18632/oncotarget.10337. View

20.

Cho J, Ahn S, Son D, Kim N, Lee K, Kim S . Bridging genomics and phenomics of gastric carcinoma. Int J Cancer. 2019; 145(9):2407-2417. DOI: 10.1002/ijc.32228. View